title: Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
authors.affiliation: Corresponding author: Allison B. Goldfine, allison.goldfine@joslin.harvard.edu.
authors.forename: Eng-Joo
authors.initials: EJ
authors.lastname: Phua
authors.forename: Ximena
authors.initials: X
authors.lastname: Lopez
authors.forename: Julia
authors.initials: J
authors.lastname: Ramus
authors.forename: Allison B
authors.initials: AB
authors.lastname: Goldfine
mesh_terms: D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007279:Injections, Subcutaneous; D061385:Insulins / Q000008:administration & dosage / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D055815:Young Adult
chemical_list: D018927:Anti-Asthmatic Agents; D007004:Hypoglycemic Agents; D061385:Insulins; D004205:Cromolyn Sodium